AML-SynergyX | Systematic identification of genetic modifiers in the response to targeted therapies in acute myeloid leukemia.
01-09-2022
-31-08-2024
Show more information
Organisation
FORSCHUNGSINSTITUT FUR MOLEKULARE PATHOLOGIE GESELLSCHAFT MBH